Cambridge Cognition (LON:COG) Stock Price Down 3.2% – What’s Next?

Cambridge Cognition Holdings Plc (LON:COG)’s stock price traded down 3.2% during mid-day trading on Thursday . The company traded as low as GBX 30 ($0.38) and last traded at GBX 30.50 ($0.38). 22,569 shares were traded during mid-day trading, a decline of 61% from the average session volume of 58,270 shares. The stock had previously closed at GBX 31.50 ($0.40).

Cambridge Cognition Stock Up 1.6 %

The stock has a market cap of £13.00 million, a P/E ratio of -785.00 and a beta of 0.72. The firm’s fifty day moving average is GBX 28.88 and its 200 day moving average is GBX 37.29. The company has a current ratio of 0.65, a quick ratio of 0.96 and a debt-to-equity ratio of 92.53.

About Cambridge Cognition

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.